Výsledky vyhledávání - "Ronald P. Landbloom"

Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder

Autor: Xiao Wu, Maju Mathews, Armin Szegedi, Sung Yun Yu, Suresh Durgam, Mary Mackle, Ronald P. Landbloom

Publikováno v: American Journal of Psychiatry. 175:71-79

The authors determined the efficacy and safety of asenapine in preventing recurrence of any mood episode in adults with bipolar I disorder.Adults with an acute manic or mixed episode per DSM-IV-TR criteria were enrolled in this randomized, placebo-co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6a38c2b87946b76fc660c9ac0f985
https://doi.org/10.1176/appi.ajp.2017.16040419

Zobrazit plný text záznamu

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder

Autor: Leslie Citrome, Ronald P. Landbloom, Cheng-Tao Chang, Willie Earley

Publikováno v: Neuropsychiatric Disease and Treatment

Leslie Citrome,1 Ronald Landbloom,2 Cheng-Tao Chang,3 Willie Earley4 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Department of Neuroscience, Merck, Whitehouse Station, NJ, USA; 3Biostatistics, Alle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a743c62b9e77b9c40cf20a858282e11
https://doi.org/10.2147/ndt.s149376

Zobrazit plný text záznamu

Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder

Autor: Mary Mackle, Xiao Wu, Maju Mathews, Ronald P. Landbloom, Terence A. Ketter, Suresh Durgam

Publikováno v: Journal of Affective Disorders. 207:384-392

Background Asenapine (ASN) is approved in the United States as monotherapy and adjunctive therapy (to lithium or valproate) in adults with bipolar mania, and as monotherapy in pediatric patients with bipolar mania. This is the first long-term study e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4215deb3a94169e4da193b5bf7ac440

Zobrazit plný text záznamu

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Autor: Mary Mackle, Suresh Durgam, Xiao Wu, Maju Mathews, Henry A. Nasrallah, Ronald P. Landbloom

Publikováno v: Neuropsychiatric Disease and Treatment

Suresh Durgam,1 Ronald P Landbloom,2 Mary Mackle,2 Xiao Wu,1 Maju Mathews,3 Henry A Nasrallah4 1Allergan Inc, Jersey City, 2Merck, Whitehouse Station, 3Forest Research Institute (now Allergan), Jersey City, NJ, 4Saint Louis University School of Medic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8884e23c4081199ed92ac76668fa335
https://www.dovepress.com/exploring-the-long-term-safety-of-asenapine-in-adults-with-schizophren-peer-reviewed-article-NDT

Zobrazit plný text záznamu

Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder

Autor: Ronald P. Landbloom, Linda Snow-Adami, Armin Szegedi, David E. Kemp, Mary Mackle, Pilar Cazorla, Jun Zhao

Publikováno v: The Journal of Clinical Psychiatry. 75:238-245

OBJECTIVE To describe weight changes and metabolic effects of asenapine compared with placebo and olanzapine in adults. METHOD Post hoc analyses were performed using data from 17 asenapine trials (13 schizophrenia and 4 bipolar mania trials) with pla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d44b383bc41fd4e411eddb344ba6b2d3
https://doi.org/10.4088/jcp.12m08271

Zobrazit plný text záznamu

Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control

Autor: Xiao Wu, Mary Mackle, Linda J. Kelly, Ronald P. Landbloom, Roger S. McIntyre, Maju Mathews, Linda Snow-Adami, Carla Hundt

Publikováno v: CNS spectrums. 22(4)

ObjectiveEvaluate the efficacy and safety of asenapine 2.5 mg twice daily (bid; n=97) or 5 mg bid (n=113) versus placebo (n=101) in adults with acute exacerbation of schizophrenia.MethodsAdults with Diagnostic and Statistical Manual of Mental Disorde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b49b8618d7cb6758d64fe54bfca9314
https://pubmed.ncbi.nlm.nih.gov/27821210

Zobrazit plný text záznamu

Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia

Autor: Marianne Z. Wamboldt, Sabine Braat, Mary Mackle, Robert L. Findling, Maju Mathews, Wendi Pallozzi, Ronald P. Landbloom, Carla Hundt

Publikováno v: Journal of child and adolescent psychopharmacology. 25(5)

The purpose of this study was to evaluate the safety and efficacy of asenapine in adolescents with schizophrenia.In an 8 week, randomized, double-blind placebo-controlled trial, subjects (12-17 years of age) meeting Diagnostic and Statistical Manual

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9402b26c4f1c68c11e3328a0432c2f3
https://pubmed.ncbi.nlm.nih.gov/26091193

Zobrazit plný text záznamu

Medical and productivity costs of anxiety disorders: case control study

Autor: Maureen J. Lage, Martin D. Marciniak, Lee Bowman, Eduardo Dunayevich, Ronald P. Landbloom

Publikováno v: Depression and anxiety. 19(2)

This retrospective case-control study examines the medical and productivity costs associated with a diagnosis of anxiety. The study used a data set from a large employer database that collected medical, pharmaceutical, absenteeism, short-term disabil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9570cbb413fd1e08b4bbed5dc52be483
https://pubmed.ncbi.nlm.nih.gov/15022146

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání